|1.||Banik, Naren L: 7 articles (05/2012 - 08/2008)|
|2.||Ray, Swapan K: 7 articles (05/2012 - 08/2008)|
|3.||Zou, Changping: 5 articles (01/2007 - 01/2005)|
|4.||Lovat, Penny E: 4 articles (01/2012 - 11/2003)|
|5.||Wang, Jian: 4 articles (01/2007 - 01/2005)|
|6.||Brewer, Molly: 4 articles (01/2007 - 01/2005)|
|7.||Lubet, Ronald A: 3 articles (09/2012 - 02/2004)|
|8.||Formelli, Franca: 3 articles (01/2010 - 10/2006)|
|9.||Cavadini, Elena: 3 articles (01/2010 - 10/2006)|
|10.||Maurer, Barry J: 3 articles (09/2008 - 08/2004)|
08/17/1994 - "N-(4-hydroxyphenyl)retinamide: a potent inducer of apoptosis in human neuroblastoma cells."
11/28/2010 - "As part of these studies we have examined anti-cancer effects on the neuroblastoma NB-39-nu cells of p-dodecylaminophenol (p-DDAP), a novel derivative of N-(4-hydroxyphenyl) retinamide (4-HPR). "
07/07/1999 - "Increase of ceramide and induction of mixed apoptosis/necrosis by N-(4-hydroxyphenyl)- retinamide in neuroblastoma cell lines."
11/01/2009 - "The present study investigated the efficacy of the combination of N-(4-hydroxyphenyl) retinamide (4-HPR, 0.5 microM) and genistein (GST, 25 microM) to control the growth of human neuroblastoma cells (SH-SY5Y and SK-N-BE2) harboring divergent molecular attributes. "
09/08/2011 - "We explored efficacy of the synthetic retinoid N-(4-hydroxyphenyl) retinamide (4-HPR) and the isoflavonoid apigenin (APG) in the serum-starved human malignant neuroblastoma cells. "
|2.||Breast Neoplasms (Breast Cancer)
07/01/1999 - "A well known breast cancer chemopreventive retinoid, N-(4-hydroxyphenyl) retinamide (4-HPR) was also included in this study for comparison. "
11/15/2004 - "The synthetic retinoid N-(4-hydroxphenyl) retinamide (4HPR) has manifold actions, which may contribute to its chemopreventive effects on breast cancer cell growth and progression. "
05/01/1998 - "A clinical trial of N-[4-hydroxyphenyl]retinamide (4-HPR) has been in progress for the past 4 years to evaluate its role in chemoprevention of breast cancer. "
05/01/1998 - "Metabolism of N-[4-hydroxyphenyl]retinamide (4-HPR) to N-[4-methoxyphenyl]retinamide (4-MPR) may serve as a biomarker for its efficacy against human breast cancer and melanoma cells."
07/01/1995 - "Modulation of markers associated with tumor aggressiveness in human breast cancer cell lines by N-(4-hydroxyphenyl) retinamide."
03/01/2006 - "For the prevention of oesophageal cancer, antitumour-B and retinamide have provided hopeful results, although it is not clear that these findings can be extrapolated from the study populations in Asia to western countries. "
11/01/1989 - "[Pharmacokinetic study of 4-(hydroxycarbophenyl) retinamide (RII) in cancer patients]."
11/01/2010 - "Treatment of cancer cells with N-(4-hydroxyphenyl) retinamide (4-HPR) induces apoptosis through destabilization of mitochondrial membrane and activation of caspase-mediated apoptotic pathways. "
01/01/2010 - "4-oxo-N-(4-hydroxyphenyl)retinamide: two independent ways to kill cancer cells."
09/01/2009 - "N-(4-hydroxyphenyl) retinamide (4-HPR), as a synthetic retinoid, has been shown to inhibit carcinogenesis in a variety of cancers. "
|4.||Prostatic Neoplasms (Prostate Cancer)
07/01/1995 - "In this study, a series of experiments were performed to examine the effects of N-(4-hydroxyphenyl) retinamide (4-HPR, Fenretinide) on cellular adhesion, motility and proteolytic activity of established prostate cancer cell lines, TSU-PR 1 and PC-3. "
03/01/1998 - "Growth inhibition of DU-145 prostate cancer cells by a Bcl-2 antisense oligonucleotide is enhanced by N-(2-hydroxyphenyl)all-trans retinamide."
01/01/1999 - "An NCI-sponsored, phase II trial of N-(4-hydroxyphenyl)- retinamide (4-HPR) in patients with organ-confined prostate cancer in the period prior to radical prostatectomy was carried out. "
01/01/2000 - "The effects of the synthetic retinoid N-(4-hydroxyphenyl) retinamide (4-HPR) on prostate cancer metastasis in vivo were evaluated in the mouse prostate reconstitution (MPR) model. "
10/01/1993 - "In a recent report, dietary fenretinide [N-[(4-hydroxyphenyl)] retinamide], a synthetic retinoid with low toxicity, decreased the incidence of experimentally induced prostate cancer. "
|5.||Urinary Bladder Neoplasms (Bladder Cancer)
06/01/2005 - "To study the mechanism of the apoptosis induced by N-[4-hydroxyphenyl] retinamide (4-HPR) in bladder cancer cell line T24, and the involvement of DNA damage and repair. "
11/01/1998 - "Although N-(4-hydroxyphenyl) retinamide (4-HPR), a retinoid derivative, has been used as a chemopreventive agent of bladder cancer in clinical trials, little is known about its mechanisms of action against bladder cancer cells. "
11/01/1998 - "Combined effect of chemopreventive agent N-(4-hydroxyphenyl) retinamide (4-HPR) and gamma-radiation on bladder cancer cell lines."
07/01/1984 - "Principal components analysis of haematological data from F344 rats with bladder cancer fed N-(ethyl)-all-trans-retinamide."
03/01/1981 - "Inhibition of urinary bladder cancer by N-(ethyl)-all-trans-retinamide and N-(2-hydroxyethyl)-all-trans-retinamide in rats and mice."
|8.||Dietary Fats (Ghee)
|9.||Ethanol (Ethyl Alcohol)
|2.||Heterologous Transplantation (Xenotransplantation)
|3.||Prostatectomy (Retropubic Prostatectomy)
|5.||Cardiopulmonary Resuscitation (CPR)